What question did this study set out to answer?

To evaluate the safety and efficacy of oral ivermectin, alone or combined with doxycycline, in accelerating virological clearance in adults hospitalized with mild COVID-19.

December 2, 2020SHILAP Revista de lepidopterologíaOpen Access

A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness

View Full Paper

Ask AI

Bookmark

Authors

SASabeena AhmedInternational Centre for Diarrhoeal Disease Research MKMohammad Mahbubul KarimInternational Centre for Diarrhoeal Disease Research ARAllen G. RossHeart Failure & Transplant

Discussion

Member takes

Implication

Randomized double-blind trial shows faster virological clearance with five-day ivermectin in mild COVID-19, suggesting potential utility in shortening viral shedding.

Key Points

To evaluate the safety and efficacy of oral ivermectin, alone or combined with doxycycline, in accelerating virological clearance in adults hospitalized with mild COVID-19.
Randomized, double-blind, placebo-controlled trial conducted among 72 hospitalized adult patients with SARS-CoV-2 in Dhaka, Bangladesh.
Patients were randomized into three arms: oral ivermectin alone (12 mg daily for 5 days), oral ivermectin plus doxycycline (12 mg single dose and doxycycline for 5 days), or placebo control.
Virological clearance occurred significantly earlier in the 5-day ivermectin arm compared to the placebo group (9.7 days vs 12.7 days; p = 0.02).
Virological clearance in the ivermectin plus doxycycline arm did not differ significantly from placebo (11.5 days vs 12.7 days; p = 0.27).
Clinical symptoms including fever, cough, and sore throat were comparable among the three groups, with no severe adverse drug events recorded.

Cite This Study

Ahmed et al. (2020) studied this question.

synapsesocial.com/papers/69dcf8128cc25b5e451333f7 https://doi.org/10.1016/j.ijid.2020.11.191

View Full Paper

Ask AI

Bookmark

Implication

Randomized double-blind trial shows faster virological clearance with five-day ivermectin in mild COVID-19, suggesting potential utility in shortening viral shedding.

A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness

Discussion

Member takes

Implication

Key Points

Cite This Study

A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider